Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
232.4 EUR | -0.77% |
|
-3.94% | -18.82% |
06-28 | Would you like some more inflation? | ![]() |
06-28 | Genmab, AbbVie's Lymphoma Therapy Recommended for Approval in EU | MT |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
121B | ||||||
113B | ||||||
26.02B | - | |||||
19.39B | - | |||||
15.09B | - |
- Stock Market
- Equities
- GMAB Stock
- GE9 Stock
- Charts Genmab A/S
- Sector Chart